CareerPlanSign in

General Manager, Alzheimer's US

💼 Full-time💰 $192,000–$192,000🗓 2026-09-02 → 2026-09-25

Core

Define and lead commercial launch strategy for novel PET-imaging agents in the Alzheimer disease area, driving market share and volume growth for GE HealthCare's Pharmaceutical Diagnostics segment.

Role type

Senior General Manager, Commercial Strategy & Execution

Builds

Novel PET-imaging agents (Vizamyl) and strategic partnerships for Alzheimer diagnostics

Domain

Healthcare / Medical Technology / Nuclear Medicine / Alzheimer's Disease

Deliverable

product features

Required skills

Commercial launch strategy, P&L management, cross-functional team leadership, key opinion leader (KOL) relationship management, product lifecycle management, strategic partnership development, sales force effectiveness, regulatory compliance, market analysis

Preferred skills

Financial reporting tools, complex contract negotiation, large complex sales processes, pharma company alignment

Technologies

None stated

Responsibilities

Define and lead commercial launch strategy for novel PET-imaging agents; implement nuclear medicine account management model; develop relationships with Key Opinion Leaders; oversee product lifecycle management; build strategic partnerships with radio pharmacies and pharma companies; empower and grow high-performing commercial teams; partner with global teams on label and portfolio expansion

Seniority

Senior, hands-on IC with strategic leadership

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.